Delivery Order SPE2DB24D9313-SPE2DB24FFFHP
Award Date
9/27/24
Potential Completion Date
10/21/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The $7,146.90 firm fixed-price delivery order has an ultimate completion date of September 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS. The firm fixed-price contract has a ceiling value of $8,331.72 and a period of performance through July 7, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $25,167.20 firm fixed-price delivery order is for the supply of 4,556,133,769 NEXPLANON 68 MG IMPLANTS. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products, including common medications and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order worth $3,471.55 issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with an ultimate completion date of April 14, 2025. DMS Pharmaceutical Group Inc....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of NEXPLANON 68 MG IMPLANTS to the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The firm fixed-price delivery order, valued at $4,288.14, was awarded on September 25, 2024, with an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $8,576.28 for the supply of NEXPLANON 68 MG IMPLANTS. The award was made by the Defense Logistics Agency (DLA) under the SPE2DB program, which is an indefinite delivery contract (IDC) with a ceiling value of up to $499,999,999 that runs through December 31, 2025. DMS Pharmaceutical Group holds this single-award IDC to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,146.90 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS and has a period of performance through December 16, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,471.55 firm fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, a pharmaceutical product, with a period of performance through April 11, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the delivery of NEXPLANON 68 MG IMPLANTS. The $6,149.60 firm fixed-price delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $41,024.40 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, which has a ceiling value of up to $499,999,999, covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This specific delivery order is for NEXPLANON 68 MG IMPLANTS, with a period of...